Symdeko Interactions
There are 474 drugs known to interact with Symdeko (ivacaftor/tezacaftor), along with 8 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 98 are major, 355 are moderate, and 21 are minor.
- View all 474 medications that may interact with Symdeko
- View Symdeko alcohol/food interactions (3)
- View Symdeko disease interactions (8)
Most frequently checked interactions
View interaction reports for Symdeko (ivacaftor / tezacaftor) and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- Advair HFA (fluticasone / salmeterol)
- albuterol
- allopurinol
- azithromycin
- Baraclude (entecavir)
- Benadryl (diphenhydramine)
- bleomycin
- Cayston (aztreonam)
- Cipro (ciprofloxacin)
- ciprofloxacin
- Creon (pancrelipase)
- Cymbalta (duloxetine)
- enalapril
- Etopophos (etoposide)
- Hyper-Sal (sodium chloride)
- ibuprofen
- Jynarque (tolvaptan)
- Kalydeco (ivacaftor)
- lansoprazole
- omeprazole
- Oncovin (vincristine)
- prednisone
- Pulmozyme (dornase alfa)
- Singulair (montelukast)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- tobramycin
- Trikafta (elexacaftor / ivacaftor / tezacaftor)
- Vitamin D3 (cholecalciferol)
- Xopenex (levalbuterol)
Symdeko alcohol/food interactions
There are 3 alcohol/food interactions with Symdeko (ivacaftor / tezacaftor).
Symdeko disease interactions
There are 8 disease interactions with Symdeko (ivacaftor / tezacaftor) which include:
- hepatic impairment
- renal impairment
- cataracts
- hepatic impairment
- hypertension
- organ transplant
- pulmonary impairment
- renal impairment
Report options
QR code containing a link to this page
More about Symdeko (ivacaftor / tezacaftor)
- Symdeko consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CFTR combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
